Css LLC Vir Biotechnology, Inc. Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$38.75 - $51.0 $19,375 - $25,500	-500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$26.34 - $83.07 $13,170 - $41,535	500 New	500 $26,000
Q4 2020 Feb 16, 2021	SELL	$25.51 - $43.38 $34,795 - $59,170	-1,364 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$28.28 - $53.6 $38,573 - $73,110	1,364 New	1,364 $47,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.